Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome

Clinica Chimica Acta

Volumn 384, Issue 1-2, 2007, Pages 24-27

  Lee, Yong Wha ^a   Kim, Ho Jung ^a   Cho, Yoon Haeng ^a   Shin, Hee Bong ^a   Choi, Tae Youn ^a   Lee, You Kyoung ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Acute coronary syndrome; Albumin adjusted IMA index; Ischemia modified albumin

Indexed keywords

SERUM ALBUMIN;

ACCURACY; ACUTE CORONARY SYNDROME; ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; BIOLOGICAL MARKERS; CORONARY DISEASE; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SYNDROME;

EID: 34547838287     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.05.003     Document Type: Article

References (12)

1. Lee T.H., Cook E.F., Weisberg M., Sargent R.K., Wilson C., and Goldman L. Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med 145 (1985) 65-69
2. Rouan G.W., Lee T.H., Cook E.F., Brand D.A., Weisberg M.C., and Goldman L. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). Am J Cardiol 64 (1989) 1087-1092
3. Brogan Jr. G.X., Hollander J.E., McCuskey C.F., et al. Evaluation of a new assay for cardiac troponin I vs. creatine kinase-MB for the diagnosis of acute myocardial infarction. Biochemical Markers for Acute Myocardial Ischemia (BAMI) Study Group. Acad Emerg Med 4 (1997) 6-12
4. Gomez M.A., Anderson J.L., Karagounis L.A., Muhlestein J.B., and Mooers F.B. An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol 28 (1996) 25-33
5. Anwaruddin S., Januzzi Jr. J.L., Baggish A.L., Lewandrowski E.L., and Lewandrowski K.B. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 123 (2005) 140-145
6. Roy D., Quiles J., Aldama G., et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 97 (2004) 297-301
7. Kang S.Y., Suh J.T., and Lee W.I. Clinical usefulness of ischemia modified albumin in acute coronary syndrome. Korean J Lab Med 25 (2005) 306-311
8. Gidenne S., Ceppa F., Fontan E., Perrier F., and Burnat P. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer. Clin Chem Lab Med 42 (2004) 455-461
9. Christenson R.H., Duh S.H., Sanhai W.R., et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47 (2001) 464-470
10. Zapico-Muniz E., Santalo-Bel M., Merce-Muntanola J., Montiel J.A., Martinez-Rubio A., and Ordonez-Llanos J. Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem 50 (2004) 1063-1065
11. Kim J.Y., Yoon J., Jung I.H., et al. A diagnostic value of ischemia modified albumin in patients with suspected acute coronary syndrome with normal EKG and cardiac markers. Korean Circ J 35 (2005) 928-933
12. Internal data from 510k premarket notification submission to USFDA. FDA Ref No. K023824;2003 [Feb 14].